Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems, «CLINICAL NUTRITION», 2021, 40, pp. 1176 - 1185 [Scientific article]
Raschi, Emanuel; Fusaroli, Michele; Diemberger, Igor; Poluzzi, Elisabetta, Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”, «DRUG SAFETY», 2021, 44, pp. 505 - 506 [Comment or similar]
Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [Scientific article]Open Access
Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [Scientific article]Open Access
Burato S.; Leonardi L.; Antonazzo I.C.; Raschi E.; Ajolfi C.; Baraghini M.; Chiarello A.; Delmonte V.; Di Castri L.; Donati M.; Fadda A.; Fedele D.; Ferretti A.; Gabrielli L.; Gobbi S.; Lughi S.; Mazzari M.; Pieraccini F.; Renzetti A.; Russi E.; Scanelli C.; Zanetti B.; Poluzzi E., Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region, «FRONTIERS IN PHARMACOLOGY», 2021, 11, Article number: 624888 , pp. 1 - 7 [Scientific article]Open Access
Luxi N.; Giovanazzi A.; Capuano A.; Crisafulli S.; Cutroneo P.M.; Fantini M.P.; Ferrajolo C.; Moretti U.; Poluzzi E.; Raschi E.; Ravaldi C.; Reno C.; Tuccori M.; Vannacci A.; Zanoni G.; Trifiro G., COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety, «DRUG SAFETY», 2021, 44, pp. 1247 - 1269 [Scientific article]
Raschi E.; Fusaroli M.; Ardizzoni A.; Poluzzi E.; De Ponti F., Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment, «BREAST CANCER RESEARCH AND TREATMENT», 2021, 186, pp. 219 - 227 [Scientific article]Open Access
Fusaroli M.; Raschi E.; Gatti M.; De Ponti F.; Poluzzi E., Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 740707 , pp. 1 - 11 [Scientific article]Open Access
Raschi E.; Antonazzo I.C.; Poluzzi E.; De Ponti F., Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list?, «ANNALS OF THE RHEUMATIC DISEASES», 2021, 80, pp. 120 - 120 [Comment or similar]
Zeneli, A; Brandi, G; Di Pasquale, G; Orlandini, D; De Carolis, P; Bravi, F; Pugliese, F; Poluzzi, E; Catena, F; Giovanardi, F; Valpiani, G; Mantovani, R; Magnanimi, E; Iannone, P., Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology, «BMJ OPEN», 2021, 11, Article number: e043239 , pp. 1 - 10 [Scientific article]Open Access
Fusaroli M.; Raschi E.; Contin M.; Sambati L.; Menchetti M.; Fioritti A.; Poluzzi E., Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list, «PARKINSONISM & RELATED DISORDERS», 2021, 90, pp. 79 - 83 [Scientific article]
Gatti, Milo; Raschi, Emanuel; Moretti, Ugo; Ardizzoni, Andrea; Poluzzi, Elisabetta; Diemberger, Igor, Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase, «VACCINES», 2021, 9, Article number: 19 , pp. 1 - 13 [Scientific article]Open Access
Scarpone, M; Bergami, M; Cenko, E; Bugiardini, R; Poluzzi, E; Manfrini, O, Previous psychiatric disorders and antipsychotic drugs in COVID-19 patients: early findings on possible worse outcome, «EUROPEAN HEART JOURNAL», 2021, 42, pp. 2753 - 2753 [Abstract]
Aiello V.; Fusaroli M.; Raschi E.; Palazzini M.; Hu L.; Barbuto S.; Poluzzi E.; Capelli I., Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry, «KIDNEY INTERNATIONAL REPORTS», 2021, 6, pp. 2472-2477 - 2477 [Scientific article]Open Access
Montalti M.; Solda' G.; Di Valerio Z.; Salussolia A.; Lenzi J.; Forcellini M.; Barvas E.; Guttmann S.; Messina R.; Poluzzi E.; Raschi E.; Riccardi R.; Fantini M.P.; La Fauci G.; Gori D., ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance, «ECLINICALMEDICINE», 2021, 38, Article number: 101027 , pp. 1 - 7 [Scientific article]Open Access
